Core Viewpoint - Burcon NutraScience Corporation has successfully closed the second tranche of its non-brokered private placement of convertible debentures, raising a total of $6.9 million, which strengthens its balance sheet and supports its production scaling and commercial execution efforts [1][3]. Group 1: Private Placement Details - The second tranche of the private placement involved the issuance of convertible debentures totaling $2.75 million, contributing to an aggregate of $4 million raised from the first and second tranches [2]. - The first tranche closed on December 31, 2025, for $1.25 million, while the final tranche of $2.90 million is expected to close prior to April 24, 2026, as a non-cash loan conversion [4]. - Insiders have subscribed to a total of $2.7 million in convertible debentures across both tranches, indicating strong insider confidence in the company [2][5]. Group 2: Company Strategy and Future Outlook - The CEO of Burcon highlighted that the successful financing marks a significant milestone, enhancing the company's ability to scale production and accelerate commercial execution [3]. - The company is committed to building long-term value and aligning stakeholders through the remaining non-cash loan conversion component of the financing [3]. - Burcon is recognized as a leader in plant-based protein innovation, with a focus on sustainability and creating high-performance protein solutions for the food and beverage industry [7].

Core Viewpoint - Burcon NutraScience Corporation has successfully obtained shareholder approval for key resolutions at its 2026 special meeting, including a private placement of convertible debentures and amendments to insider warrants [1][2]. Group 1: Shareholder Meeting Outcomes - All matters presented to shareholders were approved during the special meeting held on February 20, 2026 [1]. - Resolutions related to the Convertible Debenture Financing and amendments to the expiry date of outstanding warrants held by insiders received approval [2]. - A report detailing the voting results for each resolution has been filed on the SEDAR+ website [2]. Group 2: Financing and Future Expectations - The company anticipates closing the Convertible Debenture Financing around February 24, 2026 [3]. Group 3: Company Overview - Burcon is recognized as a global leader in high-performance plant-based proteins, catering to the food and beverage industry [4]. - The company boasts a robust patent portfolio covering proteins derived from various plant sources, including pea, canola, soy, hemp, and sunflower [4]. - Burcon is committed to sustainability and aims to provide innovative protein solutions that benefit both consumers and the environment [4].

Core Viewpoint - Burcon NutraScience Corporation is extending the expiry date of certain outstanding warrants to June 30, 2027, to facilitate cash inflow for capacity expansion and growth without incurring additional financing costs [2][3]. Group 1: Warrant Amendment Details - The expiry date of warrants held by non-insiders will be amended effective February 19, 2026, while the amendment for insider-held warrants requires disinterested shareholder approval at the upcoming meeting [2][6]. - The company has a total of 1,544,249 outstanding warrants, with specific details on the number of shares, exercise prices, and new expiry dates outlined [4]. Group 2: Financial Implications - The company anticipates that the cash inflow from the exercise of the outstanding warrants will support its plans for capacity expansion, enhancing the likelihood of warrant holders exercising their warrants [3]. - The amendment to the expiry date of warrants held by insiders is contingent upon receiving disinterested shareholder approval, which will be sought separately for each tranche of insider warrants [8][7]. Group 3: Company Overview - Burcon is recognized as a global technology leader in high-performance plant-based proteins, catering to the food and beverage industry, with a strong focus on sustainability and innovation [10]. - The company holds an extensive patent portfolio covering various plant-derived proteins, positioning itself as a key player in the growing plant-based market [10].

Core Insights - Burcon NutraScience Corporation is positioned for significant growth as it enters 2026, building on its commercial momentum and achievements in technology validation and manufacturing [2][10] Commercial Momentum and Sales Growth - Recent customer transitions from evaluation to commercial purchase orders highlight Burcon's product differentiation, including high purity and clean taste [3] - Revenue for calendar 2025 is projected to be between $1 million and $3 million, with a reaffirmed target of over $10 million for calendar 2026 due to increasing customer commitments [4] Proven Protein Technology Platform - A strategic partnership with RE ProMan LLC is enhancing the commercial deployment of Burcon's protein technology, ensuring scalable production to meet rising demand [5] - Successful validation of patented protein technologies at full commercial scale has reduced execution risk and confirmed Burcon's capability to deliver high-performance ingredients [6] Industry Demand Aligned with Burcon's Strengths - The demand for clean-label, better-tasting plant proteins is increasing among food and beverage manufacturers, aligning with Burcon's strengths and driving over 200 new customer projects [7] Financial Readiness - Burcon is finalizing a financing to support production investments and accelerate growth, with strong backing from insiders and manufacturing partners [8] - The financing aims to enhance the company's balance sheet and support near-term growth initiatives [9] Entering 2026 with Strong Momentum - Burcon is entering 2026 with a solid foundation, including proven technology, scalable facilities, and growing ingredient sales, with a clear path to achieving positive cash flow [10]

Core Viewpoint - Burcon NutraScience Corporation's insiders have increased their commitment to participate in a non-brokered private placement of convertible debentures, reflecting confidence in the company's business plan and sales trajectory as it moves into 2026 [2][3]. Group 1: Insider Participation - Insiders previously committed a minimum of $2.0 million in principal amount to the private placement [2]. - The increased interest from insiders and potential investors may require disinterested shareholder approval for the offering [2][3]. Group 2: Offering Details - The offering was initially expected to close on or about November 28, 2025, but the timeline will be extended due to increased interest and the need for shareholder approval [3]. - The company is finalizing the terms and conditions of the offering, which may differ from previous announcements, and it is subject to necessary regulatory approvals [3]. Group 3: Company Overview - Burcon is a global leader in high-performance plant-based proteins, focusing on innovation for the food and beverage industry [4]. - The company holds an extensive patent portfolio covering proteins derived from various plant sources, emphasizing sustainability and next-generation protein solutions [4].

Core Insights - Burcon NutraScience Corporation's Peazazz®C pea protein and Solatein™ sunflower protein have been shown to significantly outperform a leading competitor's pea protein in a plant-based cheese application, which is part of a multi-billion-dollar market projected to grow at double-digit rates [1][2] Company Overview - Burcon is a global technology leader in high-performance plant-based proteins for the food and beverage industry, with a focus on superior taste, texture, and functionality [4] - The company has over two decades of innovation and holds an extensive patent portfolio covering novel proteins derived from various plant sources [4] Product Performance - The study conducted by the University of Guelph demonstrated that Burcon's proteins delivered the desired characteristics of commercial mozzarella-style cheese, including stretch, melt, oil binding, and shredability, while maintaining a clean and mild flavor [2] - Peazazz C is a 90%+ purity pea protein isolate with low sodium and an exceptional taste profile, while Solatein™ is a 90%+ sunflower protein isolate featuring a neutral flavor and outstanding functional properties [3] Market Potential - The plant-based cheese market is a multi-billion-dollar industry with significant growth potential, driven by increasing consumer demand for dairy alternatives [1][7]

Core Points - Burcon NutraScience Corporation has appointed Mr. Philip Dowad and Mr. Richard Nazur Jr. as new members of its Board of Directors, enhancing its leadership as it enters a new growth phase [1][2] - The results from the 2025 annual general and special meeting of shareholders indicate that all seven nominees proposed by management were elected to the board [2][3] - Shareholders approved the appointment of KPMG LLP as auditors and the amendment to the exercise price of outstanding warrants [3] Board Member Profiles - Mr. Philip Dowad has over 43 years of experience in audit and professional practice, primarily with KPMG, and has served as a consultant and expert witness since his retirement in 2022 [4] - Mr. Richard Nazur Jr. has over 20 years of experience in agricultural commodity markets, previously working at Archer Daniels Midland Company and currently operates a successful family office involved in multiple commodity markets [6] Company Overview - Burcon NutraScience Corporation is a global leader in plant-based protein innovation, focusing on high-performance ingredients for the food and beverage industry [7] - The company holds an extensive patent portfolio covering novel proteins derived from various plant sources and is committed to sustainability and creating next-generation protein solutions [7]

Company Overview - Burcon NutraScience Corporation is a global technology leader in high-performance plant-based proteins for the food and beverage industry, with a focus on sustainability and innovation [3][2] - The company holds an extensive patent portfolio covering novel proteins derived from various plant sources, including pea, canola, soy, hemp, and sunflower [3] Financial Results and Conference Call - Burcon will hold an investor conference call and webcast on August 13, 2025, at 5:00 p.m. Eastern time to discuss its financial results for the fiscal 2026 first quarter ended June 30, 2025 [1][5] - Financial results will be issued in a press release prior to the call [1] Market Position and Growth Strategy - The company is transitioning from a technology pioneer to a revenue-generating innovation leader in the plant protein sector, with increased customer engagement following the IFT FIRST event [2] - The Galesburg facility is scaling production across Burcon's plant protein portfolio to meet growing market demand and drive sustainable long-term growth [2]